Engineered natural killer cells expressing chimeric CD64

Project: Research project

Description

Engineered natural killer cells expressing chimeric CD64 as a cancer immunotherapy
StatusFinished
Effective start/end date7/1/186/30/19

Funding

  • MN OVARIAN CANCER ALLIANCE

Fingerprint

Natural Killer Cells
Immunotherapy
Neoplasms